Fresenius Medical Care AG (FMCQF) Receivables (2009 - 2022)

Fresenius Medical Care AG has reported Receivables for 14 years, with the latest figure at $166.8 million in Q4 2022.

• On a quarterly basis, Receivables fell 20.64% year-over-year to $166.8 million in Q4 2022; TTM through Dec 2022 was $166.8 million, a 20.64% decrease from a year earlier, with the FY2022 full-year figure at $166.8 million, down 20.64% from the prior year.
• Receivables was $166.8 million for Q4 2022 at Fresenius Medical Care AG, down from $210.2 million in the prior quarter.
• The five-year high for Receivables was $4.9 billion in Q1 2018, with the low at $166.8 million in Q4 2022.
• Average Receivables over 5 years is $3.5 billion, with a median of $4.0 billion recorded in 2019.
• The sharpest annual moves came in 2018 and 2021: Receivables increased 27.01% in 2018, then tumbled 88.78% in 2021.
• Over 5 years, Receivables stood at $3.9 billion in 2018, then gained by 1.22% to $4.0 billion in 2019, then plunged by 52.73% to $1.9 billion in 2020, then sank by 88.78% to $210.2 million in 2021, then declined by 20.64% to $166.8 million in 2022.
• The last three Receivables figures came in at $166.8 million (Q4 2022), $210.2 million (Q4 2021), and $1.9 billion (Q4 2020), per Business Quant data.